XSDR.L vs. BTEK.L

Last updated Jun 5, 2026

XSDR.L (Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C) and BTEK.L (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds - XSDR.L tracks the MSCI World/Health Care NR USD while BTEK.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, XSDR.L returned 5.46%/yr vs 5.85%/yr for BTEK.L. A 0.57 correlation means they provide meaningful diversification when combined. XSDR.L charges 0.20%/yr vs 0.35%/yr for BTEK.L.

Performance

XSDR.L vs. BTEK.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XSDR.L is traded in GBp, while BTEK.L is traded in GBP. To make them comparable, the BTEK.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, XSDR.L achieves a -2.48% return, which is significantly lower than BTEK.L's 4.86% return.

XSDR.L

• 1D: 3.19%
• 1M: 1.91%
• YTD: -2.48%
• 6M: -1.52%
• 1Y: 7.47%
• 3Y*: 2.49%
• 5Y*: 5.46%
• 10Y*: 7.09%

BTEK.L

• 1D: 3.56%
• 1M: 2.25%
• YTD: 4.86%
• 6M: 2.70%
• 1Y: 43.15%
• 3Y*: 10.19%
• 5Y*: 5.85%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XSDR.L vs. BTEK.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XSDR.L Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C	-2.48%	9.44%	0.30%	6.92%	0.28%	17.06%	4.29%	23.70%	0.84%	-2.80%
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF	4.86%	23.81%	-0.32%	0.33%	-1.55%	0.90%	23.11%	21.63%	-6.34%	-3.31%

Correlation

The correlation between XSDR.L and BTEK.L is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.58
Correlation (3Y) Calculated over the trailing 3-year period	0.50
Correlation (5Y) Calculated over the trailing 5-year period	0.51
Correlation (All Time) Calculated using the full available price history since Oct 25, 2017	0.57

The correlation between XSDR.L and BTEK.L has been stable across timeframes, ranging from 0.50 to 0.58 - a consistent structural relationship.

XSDR.L vs. BTEK.L - Sectors Allocation Comparison

Sectors	XSDR.L	BTEK.L
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

XSDR.L vs. BTEK.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XSDR.L

XSDR.L Risk / Return Rank: 16
XSDR.L Sharpe Ratio Rank: 16
XSDR.L Sortino Ratio Rank: 16
XSDR.L Omega Ratio Rank: 16
XSDR.L Calmar Ratio Rank: 16
XSDR.L Martin Ratio Rank: 15

BTEK.L

BTEK.L Risk / Return Rank: 76
BTEK.L Sharpe Ratio Rank: 70
BTEK.L Sortino Ratio Rank: 70
BTEK.L Omega Ratio Rank: 63
BTEK.L Calmar Ratio Rank: 92
BTEK.L Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XSDR.L vs. BTEK.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XSDR.L	BTEK.L	Difference
Sharpe ratio: Return per unit of total volatility	0.43	2.24	-1.81
Sortino ratio: Return per unit of downside risk	0.76	3.13	-2.37
Omega ratio: Gain probability vs. loss probability	1.09	1.38	-0.29
Calmar ratio: Return relative to maximum drawdown	0.56	6.23	-5.67
Martin ratio: Return relative to average drawdown	1.31	17.55	-16.24
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XSDR.L vs. BTEK.L - Sharpe Ratio Comparison

The current XSDR.L Sharpe Ratio is 0.43, which is lower than the BTEK.L Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of XSDR.L and BTEK.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XSDR.L	BTEK.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.43	2.24	-1.81
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.34	0.29	+0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.45	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	0.31	+0.29

Drawdowns

XSDR.L vs. BTEK.L - Drawdown Comparison

The maximum XSDR.L drawdown since its inception was -25.61%, smaller than the maximum BTEK.L drawdown of -30.86%. Use the drawdown chart below to compare losses from any high point for XSDR.L and BTEK.L.

Drawdown Indicators

	XSDR.L	BTEK.L	Difference
Max Drawdown Largest peak-to-trough decline	-25.61%	-30.86%	+5.25%
Max Drawdown (1Y) Largest decline over 1 year	-13.31%	-6.89%	-6.42%
Max Drawdown (3Y) Largest decline over 3 years	-25.61%	-26.34%	+0.73%
Max Drawdown (5Y) Largest decline over 5 years	-25.61%	-30.86%	+5.25%
Max Drawdown (10Y) Largest decline over 10 years	-25.61%	—	—
Current Drawdown Current decline from peak	-11.70%	-1.86%	-9.84%
Average Drawdown Average peak-to-trough decline	-5.72%	-10.04%	+4.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.68%	2.45%	+3.23%

Volatility

XSDR.L vs. BTEK.L - Volatility Comparison

The current volatility for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR.L) is 5.64%, while iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a volatility of 6.91%. This indicates that XSDR.L experiences smaller price fluctuations and is considered to be less risky than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XSDR.L	BTEK.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.64%	6.91%	-1.27%
Volatility (6M) Calculated over the trailing 6-month period	12.17%	14.67%	-2.50%
Volatility (1Y) Calculated over the trailing 1-year period	17.23%	19.14%	-1.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.89%	20.08%	-4.19%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.85%	21.71%	-5.86%

XSDR.L vs. BTEK.L - Expense Ratio Comparison

XSDR.L has a 0.20% expense ratio, which is lower than BTEK.L's 0.35% expense ratio.

Dividends

XSDR.L vs. BTEK.L - Dividend Comparison

Neither XSDR.L nor BTEK.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both XSDR.L and BTEK.L in my portfolio?

XSDR.L and BTEK.L have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XSDR.L or BTEK.L?

On fees, XSDR.L is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XSDR.L or BTEK.L?

XSDR.L is cheaper with a 0.20% expense ratio, compared with 0.35% for BTEK.L.

What is the main difference between XSDR.L and BTEK.L?

XSDR.L tracks MSCI World/Health Care NR USD, while BTEK.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: Xtrackers and iShares. Their fees differ too: 0.20% for XSDR.L and 0.35% for BTEK.L.